State Street Corp Catalyst Biosciences, Inc. Transaction History

State Street Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$3.78 - $5.18 $110,376 - $151,256	29,200 Added 67.28%	72,599 $298,000
Q2 2021 Aug 16, 2021	SELL	$4.1 - $5.33 $1.37 Million - $1.78 Million	-334,835 Reduced 88.53%	43,399 $188,000
Q1 2021 May 17, 2021	BUY	$4.93 - $7.15 $235,654 - $341,770	47,800 Added 14.47%	378,234 $1.91 Million
Q4 2020 Feb 16, 2021	BUY	$4.55 - $7.29 $437,018 - $700,189	96,048 Added 40.98%	330,434 $2.09 Million
Q3 2020 Nov 10, 2020	BUY	$4.22 - $6.04 $122,802 - $175,764	29,100 Added 14.18%	234,386 $1.01 Million
Q2 2020 Aug 14, 2020	BUY	$3.76 - $8.01 $771,875 - $1.64 Million	205,286 New	205,286 $1.21 Million

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.